The COVID-19 pandemic has painfully exposed how unprepared we were (and still are) to effectively handle and contain infectious diseases. Point-of-care diagnostics that can provide rapid, accurate, and affordable testing is key to contain the current pandemic and prevent the next outbreaks. DxLab is focused on providing novel diagnostic tools for early, low-cost disease detection outside of high-complexity laboratories.
Company Details
- Employees
- 3
- Founded
- 2020
- Address
- 444 Somerville Ave, Somerville,massachusetts 02143,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.dxlab.bio/
- HQ
- Somerville, Massachusetts
Dxlab Inc. Questions
Dxlab Inc.'s website is https://www.dxlab.bio/
Dxlab Inc.'s LinkedIn profile is https://www.linkedin.com/company/dxlab-inc
Dxlab Inc. has
3 employees.
View email and phone details for 3
employees at Dxlab Inc..
Dxlab Inc.'s industry is
Biotechnology Research
Dxlab Inc.'s top competitors are
Gemina Labs,
Bable,
Recon Therapeutics,
Gencores,
The Advisory,
Domus Diagnostics, Inc,
Person & Covey, Inc.,
Dxlab,
Brightsens Diagnostics,
Vecx Biomedicines Inc..
Dxlab Inc.'s categories are Biotechnology Research
Dxlab Inc.'s founding year is 2020
